glp 1 and binge eating disorder GLP-1 Medications Disorders: Risks, Benefits & Mental Health Support Patients with eating disorders are

A gray market has exploded around compounded, copycat, and unapproved GLP-1 products, including semaglutide, tirzepatide, and even retatrutide sold online as research use only or not for human consumption. Its estimated that 1.5 million Americans are using compounded GLP-1 drugs , and the FDA has since warned that unapproved GLP-1 products cannot be verified for quality, safety, or efficacy

GLP-1/GIP agonists significantly reduce appetite and food intake, which is their intended mechanism for weight loss

Further details are available in Supplementary Table 1

Training plus enough protein doesnt just slow the loss, it largely protects against it

& Treiman, M

However, understanding how these medications work, potential considerations during treatment, and when to seek medical guidance ensures safe and effective use of both therapies together